QA: Regulus Therapeutics Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001505512_2014_Regulus_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001505512, Regulus Therapeutics Inc

  xvar xval
0 AssetsCurrent 117,182,000
1 IntangibleAssetsNetIncludingGoodwill 1,128,000
2 PropertyPlantAndEquipmentNet 3,768,000
3 remainder_Assets 987,000
4 LiabilitiesCurrent 10,370,000
5 LiabilitiesNoncurrent 1,459,000
6 remainder_Liabilities 17,779,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,429,000
9 ResearchAndDevelopmentExpense 29,942,000
10 remainder_Expenses 13,000
11 remainder_Revenues 19,861,000
12 remainder_NetIncome -1,145,000
13 remainder_ComprehensiveNetIncome 36,000
  yvar yval
0 Assets 123,065,000
1 Liabilities 29,608,000
2 Expenses 37,384,000
3 Revenues 19,861,000
4 StockholdersEquity 93,457,000
5 NetIncome -18,668,000
6 ComprehensiveNetIncome -18,650,000
7 BaseVar 105,549,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.42
9 EconomicCapitalRatio 3.31

Edgar->Model Mapping

Feature Distribution

Change over Time